Search results
...Presentation of Positive Interim 12-Week Results from ...Clinical Trial of ASC41 in Patients with...
KOLR - KSFX Ozarks· 7 days ago--Up to 68.2% mean relative reduction in liver fat content from baseline among biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) patients< ...
South Africa confirms first case of mpox death after five reported infected
The Independent via Yahoo News· 4 days agoHe said out of the total five recorded in the country, “two of these cases wereconfirmed in Gauteng...
Ongoing E.coli outbreak – what has happened so far?
Press Association News via AOL· 6 hours agoPeople should also not attend work, school or nursery until 48 hours after symptoms have stopped. UKHSA advises people to call NHS 111 or contact their...
Copperhead bite stories: We talked to 3 recent bite victims about their NC experiences
The News & Observer· 5 days agoWhat’s it like to be bitten by a venomous snake? The copperhead is the most common venomous snake in...
Council Post: 14 Emerging Wearable Health Technologies Transforming Remote Care
Forbes· 6 days agoFrom continuous glucose monitors to smartwatches with advanced health metrics, these innovations are...
Ontario government announces new Youth Wellness Hub in Brampton
Hospital Management via Yahoo Finance· 3 days agoThe Brampton hub will serve youth aged 12 to 25 and their families, offering free access to...
Former Napavine paramedic accused of ordering and stealing over 1,000 vials of narcotics in 2023
The Chronicle, Centralia, Wash. via Yahoo News· 4 days agoJun. 12—A former Lewis County Fire District 5 paramedic and medical services officer accused of forging forms to order between 1,200 and 1,500 vials of narcotics and then ...
Rocky Mountain Spotted Fever Mimicking Multisystem Inflammatory Syndrome in Hospitalized Children,...
Centers for Disease Control and Prevention· 3 days agoRocky Mountain Spotted Fever in Children, Mexico
Akero Therapeutics (NASDAQ:AKRO) Coverage Initiated at Wolfe Research
ETF DAILY NEWS· 5 days agoAnalysts at Wolfe Research started coverage on shares of Akero Therapeutics (NASDAQ:AKRO – Get Free Report) in a report issued on Tuesday, Benzinga reports. Evercore ISI cut their price objective ...
Akero Therapeutics, Inc. (NASDAQ:AKRO) Receives $41.13 Consensus Price Target from Analysts
ETF DAILY NEWS· 6 days agoShares of Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the nine brokerages that are covering the stock, Marketbeat ...